TNF-α Promoter Polymorphisms Predict the Response to Etanercept More Powerfully than that to Infliximab/Adalimumab in Spondyloarthritis
出版年份 2016 全文链接
标题
TNF-α Promoter Polymorphisms Predict the Response to Etanercept More Powerfully than that to Infliximab/Adalimumab in Spondyloarthritis
作者
关键词
-
出版物
Scientific Reports
Volume 6, Issue 1, Pages -
出版商
Springer Nature
发表日期
2016-09-01
DOI
10.1038/srep32202
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- TNF-alpha gene polymorphisms can help to predict response to etanercept in psoriatic patients
- (2015) C. De Simone et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Association between TNF-α (-308 A/G, -238 A/G, -857 C/T) polymorphisms and responsiveness to TNF-α blockers in spondyloarthropathy, psoriasis and Crohn's disease: a meta-analysis
- (2015) Gwan Gyu Song et al. PHARMACOGENOMICS
- The -308 TNFα and the -174 IL-6 promoter polymorphisms associate with effective anti-TNFα treatment in seronegative spondyloarthritis
- (2015) M Fabris et al. PHARMACOGENOMICS JOURNAL
- Influence of Immunogenicity on the Efficacy of Long-Term Treatment with TNFαBlockers in Rheumatoid Arthritis and Spondyloarthritis Patients
- (2015) Inesa Arstikyte et al. Biomed Research International
- The concept of spondyloarthritis: Where are we now?
- (2014) Neha Garg et al. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- TNF-α Gene Polymorphisms: Association with Disease Susceptibility and Response to Anti-TNF-α Treatment in Psoriatic Arthritis
- (2014) Giuseppe Murdaca et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The relationship between tumour necrosis factor (TNF)-α promoter andIL12B/IL-23Rgenes polymorphisms and the efficacy of anti-TNF-α therapy in psoriasis: a case-control study
- (2013) E. Gallo et al. BRITISH JOURNAL OF DERMATOLOGY
- Genetic polymorphisms of tumour necrosis factor alpha (TNF-α) promoter gene and response to TNF-α inhibitors in Spanish patients with inflammatory bowel disease
- (2013) R. López-Hernández et al. International Journal of Immunogenetics
- Association of TNF-α polymorphism with prediction of response to TNF blockers in spondyloarthritis and inflammatory bowel disease: a meta-analysis
- (2013) Qiang Tong et al. PHARMACOGENOMICS
- Pharmacogenetic Analysis of TNF, TNFRSF1A, and TNFRSF1B Gene Polymorphisms and Prediction of Response to Anti-TNF Therapy in Psoriasis Patients in the Greek Population
- (2012) Yiannis Vasilopoulos et al. Molecular Diagnosis & Therapy
- Developments in therapies for spondyloarthritis
- (2012) Joachim Sieper Nature Reviews Rheumatology
- TNF-α -857 and -1031 polymorphisms predict good therapeutic response to TNF-α blockers in Chinese Han patients with ankylosing spondylitis
- (2012) Qiang Tong et al. PHARMACOGENOMICS
- Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years
- (2009) Désirée van der Heijde et al. ARTHRITIS RESEARCH & THERAPY
- Immunogenicity does not influence treatment with etanercept in patients with ankylosing spondylitis
- (2008) M K de Vries et al. ANNALS OF THE RHEUMATIC DISEASES
- Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis
- (2008) Désirée van der Heijde et al. ARTHRITIS AND RHEUMATISM
- Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept
- (2008) D. van der Heijde et al. ARTHRITIS AND RHEUMATISM
- TNFα blockade in human diseases: An overview of efficacy and safety
- (2007) Jan Lin et al. CLINICAL IMMUNOLOGY
- Anti-TNF agents for rheumatoid arthritis
- (2003) H. E. Seymour et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started